NCT00817505View on ClinicalTrials.gov

To Evaluate the Bioavailability of a Tablet of AZD1656

PHASE1CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

September 30, 2009

Conditions

Type 1 Diabetes

Interventions

DRUG

AZD1656

Single dose oral tablet

DRUG

AZD1656

Single dose oral suspension

Trial Locations (1)

Unknown

Research site, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY